Folgen
Brett Schroeder, MD
Brett Schroeder, MD
Heme-Onc Fellow at the National Cancer Institute
Bestätigte E-Mail-Adresse bei nih.gov - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Towards a commercial process for the manufacture of genetically modified T cells for therapy
AD Kaiser, M Assenmacher, B Schröder, M Meyer, R Orentas, U Bethke, ...
Cancer gene therapy 22 (2), 72-78, 2015
2332015
COVID-19 vaccination and breakthrough infections in patients with cancer
AL Schmidt, C Labaki, CY Hsu, Z Bakouny, N Balanchivadze, SA Berg, ...
Annals of oncology 33 (3), 340-346, 2022
902022
Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data
N Shah, M Lankerovich, H Lee, JG Yoon, B Schroeder, G Foltz
BMC genomics 14, 1-15, 2013
872013
Assessment of doxorubicin and pembrolizumab in patients with advanced anthracycline-naive sarcoma: a phase 1/2 nonrandomized clinical trial
SM Pollack, MW Redman, KK Baker, MJ Wagner, BA Schroeder, ...
JAMA oncology 6 (11), 1778-1782, 2020
852020
Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene
B Lin, H Lee, JG Yoon, A Madan, E Wayner, S Tonning, P Hothi, ...
Oncotarget 6 (7), 5369, 2015
752015
Clinical benefit of trabectedin in uterine adenosarcoma
BA Schroeder, ET Rodler, ET Loggers, SM Pollack, RL Jones
Medical Oncology 30, 1-3, 2013
312013
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes
BA Schroeder, NA LaFranzo, BJ LaFleur, RM Gittelman, M Vignali, ...
Journal for immunotherapy of cancer 9 (8), 2021
232021
External ventricular drain placement accuracy and safety when done by midlevel practitioners
NR Ellens, DL Fischer, JE Meldau, BA Schroeder, SE Patra
Neurosurgery 84 (1), 235-241, 2019
212019
Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy
IV Ulasov, N Shah, NV Kaverina, H Lee, B Lin, A Lieber, ZG Kadagidze, ...
Oncotarget 6 (6), 3977, 2015
212015
Targeting gastrointestinal stromal tumors: the role of regorafenib
B Schroeder, Z Li, LD Cranmer, RL Jones, SM Pollack
OncoTargets and therapy, 3009-3016, 2016
192016
MT1-MMP silencing by an shRNA-armed glioma-targeted conditionally replicative adenovirus (CRAd) improves its anti-glioma efficacy in vitro and in vivo
I Ulasov, AV Borovjagin, N Kaverina, B Schroeder, N Shah, B Lin, ...
Cancer Letters 365 (2), 240-250, 2015
192015
A systematic framework to rapidly obtain data on patients with cancer and COVID-19: CCC19 governance, protocol, and quality assurance
M Abidi, DM Aboulafia, MK Accordino, JD Acoba, MS Ahluwalia, ...
Cancer cell 38 (6), 761-766, 2020
182020
Oncolytic adenoviruses: a thorny path to glioma cure
IV Ulasov, AV Borovjagin, BA Schroeder, AY Baryshnikov
Genes & diseases 1 (2), 214-226, 2014
182014
MGMT methylation in glioblastoma: tale of the tail
N Shah, B Schroeder, C Cobbs
Neuro-oncology 17 (1), 167-168, 2015
172015
B7-H3 specific CAR T cells for the naturally occurring, spontaneous canine sarcoma model
S Zhang, RG Black, K Kohli, BJ Hayes, C Miller, A Koehne, BA Schroeder, ...
Molecular cancer therapeutics 21 (6), 999-1009, 2022
152022
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy
K Kohli, L Yao, TS Nowicki, S Zhang, RG Black, BA Schroeder, EA Farrar, ...
Journal for immunotherapy of cancer 9 (5), 2021
122021
Toll-like receptor 4 agonist injection with concurrent radiotherapy in patients with metastatic soft tissue sarcoma: A phase 1 nonrandomized controlled trial
YD Seo, H Lu, G Black, K Smythe, Y Yu, C Hsu, J Ng, PH De Viveiros, ...
JAMA oncology 9 (12), 1660-1668, 2023
92023
ATR inhibition augments the efficacy of lurbinectedin in small‐cell lung cancer
CW Schultz, Y Zhang, R Elmeskini, A Zimmermann, H Fu, Y Murai, ...
EMBO Molecular Medicine 15 (8), e17313, 2023
92023
Assessment of regional variability in COVID-19 outcomes among patients with cancer in the United States
JE Hawley, T Sun, DD Chism, N Duma, JC Fu, NTN Gatson, S Mishra, ...
JAMA network open 5 (1), e2142046-e2142046, 2022
92022
Durable tumor regression in highly refractory metastatic KIT/PDGFRA wild-type GIST following treatment with nivolumab
BA Schroeder, K Kohli, RB O’Malley, TS Kim, RL Jones, RH Pierce, ...
Oncoimmunology 9 (1), 1710064, 2020
92020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20